Skid Steer
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Long-Acting Injectables Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Long-Acting Injectables Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Small and Middle Sized Molecule
1.2.3 Large Sized Molecule
1.3 Market by Application
1.3.1 Global Long-Acting Injectables Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Schizophrenia
1.3.3 Other Psychotic Disorders
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Long-Acting Injectables Market Perspective (2017-2028)
2.2 Long-Acting Injectables Growth Trends by Region
2.2.1 Long-Acting Injectables Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Long-Acting Injectables Historic Market Size by Region (2017-2022)
2.2.3 Long-Acting Injectables Forecasted Market Size by Region (2023-2028)
2.3 Long-Acting Injectables Market Dynamics
2.3.1 Long-Acting Injectables Industry Trends
2.3.2 Long-Acting Injectables Market Drivers
2.3.3 Long-Acting Injectables Market Challenges
2.3.4 Long-Acting Injectables Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Long-Acting Injectables Players by Revenue
3.1.1 Global Top Long-Acting Injectables Players by Revenue (2017-2022)
3.1.2 Global Long-Acting Injectables Revenue Market Share by Players (2017-2022)
3.2 Global Long-Acting Injectables Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Long-Acting Injectables Revenue
3.4 Global Long-Acting Injectables Market Concentration Ratio
3.4.1 Global Long-Acting Injectables Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Long-Acting Injectables Revenue in 2021
3.5 Long-Acting Injectables Key Players Head office and Area Served
3.6 Key Players Long-Acting Injectables Product Solution and Service
3.7 Date of Enter into Long-Acting Injectables Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Long-Acting Injectables Breakdown Data by Type
4.1 Global Long-Acting Injectables Historic Market Size by Type (2017-2022)
4.2 Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028)
5 Long-Acting Injectables Breakdown Data by Application
5.1 Global Long-Acting Injectables Historic Market Size by Application (2017-2022)
5.2 Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Long-Acting Injectables Market Size (2017-2028)
6.2 North America Long-Acting Injectables Market Size by Country (2017-2022)
6.3 North America Long-Acting Injectables Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Long-Acting Injectables Market Size (2017-2028)
7.2 Europe Long-Acting Injectables Market Size by Country (2017-2022)
7.3 Europe Long-Acting Injectables Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Long-Acting Injectables Market Size (2017-2028)
8.2 Asia-Pacific Long-Acting Injectables Market Size by Country (2017-2022)
8.3 Asia-Pacific Long-Acting Injectables Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Long-Acting Injectables Market Size (2017-2028)
9.2 Latin America Long-Acting Injectables Market Size by Country (2017-2022)
9.3 Latin America Long-Acting Injectables Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Long-Acting Injectables Market Size (2017-2028)
10.2 Middle East & Africa Long-Acting Injectables Market Size by Country (2017-2022)
10.3 Middle East & Africa Long-Acting Injectables Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Long-Acting Injectables Introduction
11.1.4 Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022)
11.1.5 Eli Lilly Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Long-Acting Injectables Introduction
11.2.4 Pfizer Revenue in Long-Acting Injectables Business (2017-2022)
11.2.5 Pfizer Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Long-Acting Injectables Introduction
11.3.4 GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Long-Acting Injectables Introduction
11.4.4 Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022)
11.4.5 Johnson & Johnson Recent Development
11.5 Lupin
11.5.1 Lupin Company Detail
11.5.2 Lupin Business Overview
11.5.3 Lupin Long-Acting Injectables Introduction
11.5.4 Lupin Revenue in Long-Acting Injectables Business (2017-2022)
11.5.5 Lupin Recent Development
11.6 Zogenix
11.6.1 Zogenix Company Detail
11.6.2 Zogenix Business Overview
11.6.3 Zogenix Long-Acting Injectables Introduction
11.6.4 Zogenix Revenue in Long-Acting Injectables Business (2017-2022)
11.6.5 Zogenix Recent Development
11.7 DURECT
11.7.1 DURECT Company Detail
11.7.2 DURECT Business Overview
11.7.3 DURECT Long-Acting Injectables Introduction
11.7.4 DURECT Revenue in Long-Acting Injectables Business (2017-2022)
11.7.5 DURECT Recent Development
11.8 Medincel
11.8.1 Medincel Company Detail
11.8.2 Medincel Business Overview
11.8.3 Medincel Long-Acting Injectables Introduction
11.8.4 Medincel Revenue in Long-Acting Injectables Business (2017-2022)
11.8.5 Medincel Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Long-Acting Injectables Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Small and Middle Sized Molecule
Table 3. Key Players of Large Sized Molecule
Table 4. Global Long-Acting Injectables Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Long-Acting Injectables Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Long-Acting Injectables Market Share by Region (2017-2022)
Table 8. Global Long-Acting Injectables Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Long-Acting Injectables Market Share by Region (2023-2028)
Table 10. Long-Acting Injectables Market Trends
Table 11. Long-Acting Injectables Market Drivers
Table 12. Long-Acting Injectables Market Challenges
Table 13. Long-Acting Injectables Market Restraints
Table 14. Global Long-Acting Injectables Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Long-Acting Injectables Market Share by Players (2017-2022)
Table 16. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021)
Table 17. Ranking of Global Top Long-Acting Injectables Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Long-Acting Injectables Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Long-Acting Injectables Product Solution and Service
Table 21. Date of Enter into Long-Acting Injectables Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Long-Acting Injectables Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Long-Acting Injectables Revenue Market Share by Type (2017-2022)
Table 25. Global Long-Acting Injectables Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Long-Acting Injectables Revenue Market Share by Type (2023-2028)
Table 27. Global Long-Acting Injectables Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Long-Acting Injectables Revenue Market Share by Application (2017-2022)
Table 29. Global Long-Acting Injectables Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Long-Acting Injectables Revenue Market Share by Application (2023-2028)
Table 31. North America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Long-Acting Injectables Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Long-Acting Injectables Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Long-Acting Injectables Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Long-Acting Injectables Market Size by Country (2023-2028) & (US$ Million)
Table 41. Eli Lilly Company Detail
Table 42. Eli Lilly Business Overview
Table 43. Eli Lilly Long-Acting Injectables Product
Table 44. Eli Lilly Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 45. Eli Lilly Recent Development
Table 46. Pfizer Company Detail
Table 47. Pfizer Business Overview
Table 48. Pfizer Long-Acting Injectables Product
Table 49. Pfizer Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 50. Pfizer Recent Development
Table 51. GlaxoSmithKline Company Detail
Table 52. GlaxoSmithKline Business Overview
Table 53. GlaxoSmithKline Long-Acting Injectables Product
Table 54. GlaxoSmithKline Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 55. GlaxoSmithKline Recent Development
Table 56. Johnson & Johnson Company Detail
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Long-Acting Injectables Product
Table 59. Johnson & Johnson Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 60. Johnson & Johnson Recent Development
Table 61. Lupin Company Detail
Table 62. Lupin Business Overview
Table 63. Lupin Long-Acting Injectables Product
Table 64. Lupin Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 65. Lupin Recent Development
Table 66. Zogenix Company Detail
Table 67. Zogenix Business Overview
Table 68. Zogenix Long-Acting Injectables Product
Table 69. Zogenix Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 70. Zogenix Recent Development
Table 71. DURECT Company Detail
Table 72. DURECT Business Overview
Table 73. DURECT Long-Acting Injectables Product
Table 74. DURECT Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 75. DURECT Recent Development
Table 76. Medincel Company Detail
Table 77. Medincel Business Overview
Table 78. Medincel Long-Acting Injectables Product
Table 79. Medincel Revenue in Long-Acting Injectables Business (2017-2022) & (US$ Million)
Table 80. Medincel Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long-Acting Injectables Market Share by Type: 2021 VS 2028
Figure 2. Small and Middle Sized Molecule Features
Figure 3. Large Sized Molecule Features
Figure 4. Global Long-Acting Injectables Market Share by Application in 2021 & 2028
Figure 5. Schizophrenia Case Studies
Figure 6. Other Psychotic Disorders Case Studies
Figure 7. Long-Acting Injectables Report Years Considered
Figure 8. Global Long-Acting Injectables Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Long-Acting Injectables Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Long-Acting Injectables Market Share by Region: 2021 VS 2028
Figure 11. Global Long-Acting Injectables Market Share by Players in 2021
Figure 12. Global Top Long-Acting Injectables Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-Acting Injectables as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Long-Acting Injectables Revenue in 2021
Figure 14. North America Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America Long-Acting Injectables Market Share by Country (2017-2028)
Figure 16. United States Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Long-Acting Injectables Market Share by Country (2017-2028)
Figure 20. Germany Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Long-Acting Injectables Market Share by Region (2017-2028)
Figure 28. China Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Long-Acting Injectables Market Share by Country (2017-2028)
Figure 36. Mexico Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Long-Acting Injectables Market Share by Country (2017-2028)
Figure 40. Turkey Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia Long-Acting Injectables Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Eli Lilly Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 43. Pfizer Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 44. GlaxoSmithKline Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 45. Johnson & Johnson Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 46. Lupin Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 47. Zogenix Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 48. DURECT Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 49. Medincel Revenue Growth Rate in Long-Acting Injectables Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly Pfizer GlaxoSmithKline Johnson & Johnson Lupin Zogenix DURECT Medincel